OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa purchased 158,730 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were acquired at an average price of $0.63 per share, for a total transaction of $99,999.90. Following the purchase, the director directly owned 17,088,874 shares in the company, valued at approximately $10,765,990.62. The trade was a 0.94% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Thomas Kosasa also recently made the following trade(s):
- On Monday, May 18th, Thomas Kosasa purchased 268,817 shares of OneMedNet stock. The shares were acquired at an average price of $0.93 per share, for a total transaction of $249,999.81.
- On Thursday, April 23rd, Thomas Kosasa purchased 280,898 shares of OneMedNet stock. The shares were acquired at an average price of $0.89 per share, for a total transaction of $249,999.22.
OneMedNet Price Performance
Shares of OneMedNet stock opened at $0.60 on Thursday. The company’s fifty day simple moving average is $0.85 and its 200-day simple moving average is $0.95. The stock has a market capitalization of $32.78 million, a PE ratio of -12.05 and a beta of 1.12. OneMedNet Corporation has a 1-year low of $0.33 and a 1-year high of $4.22.
Institutional Trading of OneMedNet
A number of institutional investors and hedge funds have recently bought and sold shares of ONMD. HRT Financial LP purchased a new stake in shares of OneMedNet during the 4th quarter valued at about $32,000. Virtu Financial LLC bought a new stake in OneMedNet during the fourth quarter worth approximately $48,000. Jane Street Group LLC bought a new stake in OneMedNet during the fourth quarter worth approximately $119,000. State Street Corp increased its stake in OneMedNet by 41.5% during the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after acquiring an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC increased its stake in OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after acquiring an additional 45,401 shares during the last quarter. 0.95% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on ONMD. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, OneMedNet has a consensus rating of “Sell”.
Read Our Latest Report on OneMedNet
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Further Reading
- Five stocks we like better than OneMedNet
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
